IL18BP and neoplasm: WTX-518, an IL-18 pro-drug resistant to IL-18BP inhibition, is conditionally activated within the tumor microenvironment, promotes increased influx and activation of NK cells and polyfunctional CD8 T cells, and induces regressions in mouse tumor models (Morris, 2024) [139].